Techne Corporation (NASDAQ:TECH), a Minneapolis hematology specialist also known as Bio-Techne Corporation (NASDAQ:TECH), shot past expectations with revenue of $95.6 million, well above the expected $92.5 million, and adjusted earnings per share of 94 cents, which was 5 cents above expectations. Techne Corporation (NASDAQ:TECH) stock performance was 8.30% in last session and finished the day at $90.84. Traded volume was 450,920.00million shares in the last … Continue reading Bullish Stocks At NASDAQ: Techne Corporation (NASDAQ:TECH), Flamel Technologies (NASDAQ:FLML), Prosensa Holding (NASDAQ:RNA), Alliance Fiber Optic Products (NASDAQ:AFOP)